145 related articles for article (PubMed ID: 37702231)
1. Glucocorticoids, COVID-19 and Cryptococcosis.
Dos Santos WM; Rogerio AP
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):67-70. PubMed ID: 37702231
[TBL] [Abstract][Full Text] [Related]
2. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
mBio; 2012; 3(3):. PubMed ID: 22570277
[TBL] [Abstract][Full Text] [Related]
3. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
4. [A case of
Huang YQ; Xi W; Sun KK; Liu J; Feng RE; Gao ZC
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Feb; 46(2):164-167. PubMed ID: 36740377
[TBL] [Abstract][Full Text] [Related]
5. Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021.
Chang CC; Hall V; Cooper C; Grigoriadis G; Beardsley J; Sorrell TC; Heath CH;
Intern Med J; 2021 Nov; 51 Suppl 7():118-142. PubMed ID: 34937137
[TBL] [Abstract][Full Text] [Related]
6. MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients With Cryptococcus neoformans or Cryptococcus gattii Infections.
Baddley JW; Chen SC; Huisingh C; Benedict K; DeBess EE; Galanis E; Jackson BR; MacDougall L; Marsden-Haug N; Oltean H; Perfect JR; Phillips P; Sorrell TC; Pappas PG
Clin Infect Dis; 2021 Oct; 73(7):1133-1141. PubMed ID: 33772538
[TBL] [Abstract][Full Text] [Related]
7. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis of 16 cases of pulmonary cryptococcosis in patients with normal immune function.
Zhang J; Zhang D; Xue X; Yang L; Chen L; Pan L
Ann Palliat Med; 2020 May; 9(3):1117-1124. PubMed ID: 32434369
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcus and cryptococcosis in Cuba. A minireview.
Illnait-Zaragozi MT; Martínez-Machín GF; Fernández-Andreu CM; Perurena-Lancha MR; Hagen F; Meis JF
Mycoses; 2014 Dec; 57(12):707-17. PubMed ID: 25420448
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with Recombinant
Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
[TBL] [Abstract][Full Text] [Related]
12. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary cryptococcosis.
Brizendine KD; Baddley JW; Pappas PG
Semin Respir Crit Care Med; 2011 Dec; 32(6):727-34. PubMed ID: 22167400
[TBL] [Abstract][Full Text] [Related]
14. Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.
Carvajal SK; Melendres J; Escandón P; Firacative C
Microbiol Spectr; 2023 Aug; 11(4):e0140323. PubMed ID: 37341584
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus gattii infections: contemporary aspects of epidemiology, clinical manifestations and management of infection.
McMullan BJ; Sorrell TC; Chen SC
Future Microbiol; 2013 Dec; 8(12):1613-31. PubMed ID: 24266360
[TBL] [Abstract][Full Text] [Related]
16. Intra-abdominal cryptococcosis by Cryptococcus gattii: case report and review.
Araújo BS; Bay M; Reichert R; Goldani LZ
Mycopathologia; 2012 Jul; 174(1):81-5. PubMed ID: 22246960
[TBL] [Abstract][Full Text] [Related]
17. Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus).
Kido N; Makimura K; Kamegaya C; Shindo I; Shibata E; Omiya T; Yamamoto Y
Med Mycol; 2012 Apr; 50(3):291-8. PubMed ID: 21859391
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls in Serological Diagnosis of Cryptococcus gattii Infections.
Tintelnot K; Hagen F; Han CO; Seibold M; Rickerts V; Boekhout T
Med Mycol; 2015 Nov; 53(8):874-9. PubMed ID: 26337090
[TBL] [Abstract][Full Text] [Related]
19. Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.
Silva VKA; May RC; Rodrigues ML
Med Mycol; 2020 Oct; 58(7):928-937. PubMed ID: 31915833
[TBL] [Abstract][Full Text] [Related]
20. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
